Document Detail


Brain SPECT imaging in Huntington's disease before and after therapy with olanzapine. Case report.
MedLine Citation:
PMID:  10751925     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Olanzapine, an atypical antipsychotic drug, was administered to a patient with Huntington's disease (HD) with marked choreiform movements. Brain SPECT with 99mTc-HMPAO was performed before and after treatment. Brain SPECT imaging has been performed in patients with HD in order to determine the status of basal ganglia perfusion. The use of brain SPECT with 99mTc-HMPAO before and after treatment in patients with HD has not been yet reported. The marked hypoperfusion of the basal ganglia on brain SPECT performed before therapy with olanzapine improved significantly after treatment.
Authors:
E C Etchebehere; M C Lima; W Passos; J A Maciel Júnior; A O Santos; C D Ramos; E E Camargo
Related Documents :
16049045 - Quantitative diffusion tensor imaging in cerebral palsy due to periventricular white ma...
22492505 - Recognition of heat-shock protein 60 epitopes in children with type 1 diabetes.
3974825 - Intracranial space-occupying lesions in acquired immune deficiency syndrome patients.
18403805 - Assessment of traumatic brain injury and anterior pituitary dysfunction in adolescents.
1562115 - Induction of tu abnormalities in patients with torsades de pointes.
1941815 - Serum osteocalcin levels in rheumatoid arthritis: a marker for accelerated bone turnove...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Arquivos de neuro-psiquiatria     Volume:  57     ISSN:  0004-282X     ISO Abbreviation:  Arq Neuropsiquiatr     Publication Date:  1999 Sep 
Date Detail:
Created Date:  2000-04-20     Completed Date:  2000-04-20     Revised Date:  2009-11-11    
Medline Journal Info:
Nlm Unique ID:  0125444     Medline TA:  Arq Neuropsiquiatr     Country:  BRAZIL    
Other Details:
Languages:  eng     Pagination:  863-6     Citation Subset:  IM    
Affiliation:
Department of Radiology, Faculdade de Ciências Médicas (FCM) da Universidade Estadual de Campinas (UNICAMP), Brazil. elba@mn-d.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Antipsychotic Agents / therapeutic use*
Benzodiazepines
Brain / radionuclide imaging*
Female
Humans
Huntington Disease / drug therapy*,  radionuclide imaging
Pirenzepine / analogs & derivatives*,  therapeutic use
Radiopharmaceuticals / diagnostic use
Technetium Tc 99m Exametazime / diagnostic use
Tomography, Emission-Computed, Single-Photon*
Chemical
Reg. No./Substance:
0/Antipsychotic Agents; 0/Radiopharmaceuticals; 100504-35-6/Technetium Tc 99m Exametazime; 12794-10-4/Benzodiazepines; 132539-06-1/olanzapine; 28797-61-7/Pirenzepine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Magnetic resonance imaging and clinical features in adults with monophasic demyelinating disease. Ac...
Next Document:  Juvenile Huntington's disease confirmed by genetic examination in twins.